ストックスクリーナーアプリを入手
1.21
2.42%
-0.03
アフターアワーズ：
1.21
Entera Bio Ltd (ENTX) 最新ニュース
Entera Bio Ltd. (ENTX) Q1 2026 Earnings: Narrower-Than-Expected Loss Drives Strong Earnings BeatRevenue Estimate Trend - Newser
Entera Bio (ENTX) Q1 2026 Earnings: Narrowing Losses as Cash Burn Remains in FocusCommunity Buy Alerts - Newser
Entera Bio (ENTX) Faces Selling Pressure as Stock Dips Below Key ResistancePrice Action Signals - Newser
[EFFECT] Entera Bio Ltd. SEC Filing - Stock Titan
Entera Bio (NASDAQ: ENTX) registers 19.6M shares; $14.5M possible on warrant exercises - Stock Titan
Entera Bio Ltd.Ordinary Shares (NQ: ENTX - FinancialContent
Entera Bio (ENTX) shareholder vote set for July 14, 2026; 2.5M-share plan increase - Stock Titan
TradingKey - TradingKey
Number of shareholders of Entera Bio Ltd. – HAM:5DT - TradingView
MSN Money - MSN
Entera Bio Sees Funding Sufficient Through 1Q27 >ENTX - Moomoo
Entera Bio Highlights Q1 2026 Progress and Financing - TipRanks
Entera Bio (ENTX) grants COO 72,993 RSUs in lieu of cash bonus - Stock Titan
Entera Bio (ENTX) CFO receives 58,394 RSUs through A2Z Counseling Ltd. - Stock Titan
Entera Bio (ENTX) awards 87,591 RSUs to Chief of R&D Burshtein - Stock Titan
Entera Bio Ltd. (NASDAQ: ENTX) registers 19.6M shares for resale under S-3 - Stock Titan
Entera Bio Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Entera Bio (ENTX) widens Q1 loss as R&D doubles and cash runway nears Q1 2027 - Stock Titan
Entera pushes an osteoporosis pill toward Phase 3 as cash hits $20.4M - Stock Titan
Entera Bio (NASDAQ: ENTX) details Q1 2026 loss and cash runway to 2027 - Stock Titan
Press Release: Entera Announces First Quarter 2026 Financial Results and Updates Across Its Oral Peptide Programs - Moomoo
How Entera Bio (ENTX) performance reflects its true potential (Smart Money Flows) 2026-05-06Verified Stock Signals - newser.com
Entera Bio (ENTX) upgraded to buy: Here's what you should know - MSN
Entera Bio (ENTX) to Release Earnings on Friday - MarketBeat
Entera Bio (ENTX) Upgraded to Buy: Here's What You Should Know - sharewise.com
HC Wainwright Has Strong Estimate for Entera Bio Q1 Earnings - MarketBeat
What is HC Wainwright's Estimate for Entera Bio Q1 Earnings? - MarketBeat
ENTX - Finviz
HC Wainwright Has Lowered Expectations for Entera Bio (NASDAQ:ENTX) Stock Price - MarketBeat
H.C. Wainwright lowers Entera Bio stock price target on dilution By Investing.com - Investing.com South Africa
Entera Bio Price Target Cut to $9.00/Share From $10.00 by HC Wainwright & Co. - Moomoo
H.C. Wainwright lowers Entera Bio stock price target on dilution - Investing.com
Entera Bio Touts EB613 Oral Anabolic Tablet as Osteoporosis Care Gap Persists, Phase III Near - MarketBeat
Leading Osteoporosis Experts Are Lining Up Behind Entera Bio (NASDAQ: ENTX) - TradingView
Articles from Entera Bio Ltd. - FinancialContent
ENTX (Entera Bio Ltd. Ordinary Shares) rises 4.42 percent on Q4 2025 EPS beat despite sharp year over year revenue decline.Post Announcement - Xã Thanh Hà
ENTX (Entera Bio Ltd. Ordinary Shares) Q4 2025 narrower than expected loss pushes shares 6.67 percent higher in daily trading.Trending Volume Leaders - Xã Thanh Hà
ENTX (Entera Bio Ltd. Ordinary Shares) tops Q4 2025 EPS estimates, shares climb nearly seven percent on upbeat investor reaction.Real Trader Insights - Cổng thông tin điện tử tỉnh Tây Ninh
ENTX: Oral anabolic EB613 could transform osteoporosis care by improving access and adherence - TradingView
ENTX: Oral anabolic EB613 could close major osteoporosis treatment gaps and improve patient outcomes - TradingView
BriefCast Publishes Transcript: Entera Bio's Osteoporosis KOL Roundtable on EB613Oral Anabolic Tablet Opportunity - Yahoo Finance
Entera Bio (ENTX) Stock: Institutional Signals (Technical Weakness) 2026-04-20Low Risk Entry - Cổng thông tin điện tử tỉnh Lào Cai
Entera Bio (ENTX) Stock: Worth Buying? (Investor Interest) 2026-04-18Fundamentals - Xã Châu Thành
0.98%
0.12%
大文字化:
|
ボリューム (24 時間):